Freidenrich Center for Translational Research (CTRU), Stanford University — Palo Alto, California

Freidenrich Center for Translational Research (CTRU), Stanford University is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Freidenrich Center for Translational Research (CTRU), Stanford University has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Freidenrich Center for Translational Research (CTRU), Stanford University?

Freidenrich Center for Translational Research (CTRU), Stanford University has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Freidenrich Center for Translational Research (CTRU), Stanford University conducted?

Freidenrich Center for Translational Research (CTRU), Stanford University has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia.

Is Freidenrich Center for Translational Research (CTRU), Stanford University accredited by Crixeo Health?

Freidenrich Center for Translational Research (CTRU), Stanford University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Freidenrich Center for Translational Research (CTRU), Stanford University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.